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RESULTS
Figure 2: Average bone strength (N) determined by 3 point bending test for the 4 different groups.
Figure 3: TNFα concentration values across the 4 different groups
Sleep deprivation has become increasingly prevalent among
industrialized nations, and the average sleep duration for people in the
United States of America has decreased from 9 hours per night in 1910
to 7 hours per night in 2010. Sleep deprivation has been linked to
osteoporosis, a chronic metabolic skeletal disease characterized by low
bone mass and microarchitectural degradation of bone tissue as an
imbalance of osteoblasts and osteoclasts. Sleep deprivation also
disrupts the Circadian rhythm of humans, which not only challenges
the immune system, but compounds the deleterious effects of post-
menopausal estrogen deficiency. Immunologic cytokines, such as
tumor necrosis factor alpha-type (TNFα) are elevated in periods of
stress associated with sleep deprivation. TNFα is involved in systemic
inflammation, fever, cell apoptosis, and it has been shown to directly
and indirectly increase osteoclastic activity. Bisphosphonates, like
Zoledronate, are the most commonly-prescribed treatment for
osteoporosis because they decrease osteoclastic
activity. Bisphosphonates are a class of bone-seeking agents that are
selectively internalized by osteoclasts and inhibit bone resorption
through accumulation of toxic metabolites within osteoclasts, leading
to apoptosis. This study evaluates the effects of chronic sleep
deprivation and Zoledronate on the concentration of tumor necrosis
factor alpha (TNFα), and the relative bone strength of female,
ovariectomized (OVX) Wistar rats (simulating menopause) subjected
to a five-week sleep deprivation protocol.
Thirty-two female, ovariectomized (OVX) Wistar rats (x̄ mass = 386±
6.74 g) were randomly placed in control (C), Zoledronate (Z), sleep
deprived (SD), sleep deprived with Zoledronate (SDZ) groups. SD and
SDZ groups placed in MMPM tank (figure below). C and Z groups
placed in control tank. Groups were administered injections of either
0.9% saline solution or Zoledronate (50 µg/ml). Rats were given a one
week adaptation period prior to the start of the sleep deprivation
protocol. Sleep deprivation groups were randomized into 3 different
sleep deprivation protocols. Following experimental protocol, rats
were humanely sacrificed and blood serum was collected and was
added to TNFa ELISA Assay. Rat femurs were harvested, cleaned
with a saline (0.9%NaCl) and dried, then placed on apparatus to
perform 3-Point Bending Test. Force displacement data was collected.
Significant changes in overall bone strength were not found as a result
of sleep deprivation or Zoledronate injection over the course of this
five-week study. The lack of significant changes may be attributed to
the short time frame of the study and was not long enough to detect
significant microarchitectural differences in the bone. However, TNFα
levels in the blood were significantly higher in the Z group compared
to the other groups; this may be attributable to Zoledronate’s
propensity to induce transient fever for twenty-one days after injection.
SD and SDZ groups were comparable with C group, which may may
be attributable to a challenge of the animals’ immune systems. Further
research measuring the differences in average bone strength for a
longer experimental period will determine if Zoledronate and sleep
deprivation play a significant role in the degradation of bone in rats. As
sleep deprivation and a post-menopausal status is common in women
with career and family, research involving sleep-deprived,
ovariectomized rats may lay the foundation for a better understanding
of the factors affecting bone health among aging executive women.
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Figure 1: Modified Multiple Platform Method (MMPM) 
utilized for rats in sleep deprivation group.
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